[1]
|
Llovet, J.M., Kelley, R.K., Villanueva, A., et al. (2021) Hepatocellular Carcinoma. Nature Reviews Disease Primers, 7, Article No. 6. https://doi.org/10.1038/s41572-020-00240-3
|
[2]
|
中华人民共和国国家卫生健康委员会医政医管局. 原发性肝癌诊疗指南(2022年版) [J]. 中华肝脏病杂志, 2022, 30(4): 367-388.
|
[3]
|
Huang, D.Q., El-Serag, H.B. and Loomba, R. (2021) Global Epidemiology of NAFLD-Related HCC: Trends, Predictions, Risk Factors and Preven-tion. Nature Reviews Gastroenterology & Hepatology, 18, 223-238.
https://doi.org/10.1038/s41575-020-00381-6
|
[4]
|
Van Den Broek, M.A.J., Olde Damink, S.W.M., Dejong, C.H.C., et al. (2008) Liver Failure after Partial Hepatic Resection: Definition, Pathophysiology, Risk Factors and Treat-ment. Liver International, 28, 767-780.
https://doi.org/10.1111/j.1478-3231.2008.01777.x
|
[5]
|
Shoup, M., Gonen, M., D’Angelica, M., et al. (2003) Volumetric Analysis Predicts Hepatic Dysfunction in Patients Undergoing Major Liver Resection. Journal of Gastroin-testinal Surgery, 7, 325-330.
https://doi.org/10.1016/S1091-255X(02)00370-0
|
[6]
|
Lin, X.J., Yang, J., Chen, X.B., et al. (2014) The Critical Value of Remnant Liver Volume-to-Body Weight Ratio to Estimate Posthepatectomy Liver Failure in Cirrhotic Patients. Journal of Surgical Research, 188, 489-495.
https://doi.org/10.1016/j.jss.2014.01.023
|
[7]
|
Laurent, C., Sa Cunha, A., Couderc, P., et al. (2003) Influence of Postoperative Morbidity on Long-Term Survival Following Liver Resection for Colorectal Metastases. British Journal of Surgery, 90, 1131-1136.
https://doi.org/10.1002/bjs.4202
|
[8]
|
谢浩荣, 王恺, 周杰. 白蛋白-胆红素评分与Child-Pugh评分预测肝癌患者术后肝功能衰竭的效果比较[J]. 中华肝胆外科杂志, 2018, 24(3): 173-178.
|
[9]
|
Wong, W.G., Perez Holguin, R.A., Tarren, A.Y., et al. (2022) Albumin-Bilirubin Score Is Superior to Platelet-Albumin- Bilirubin Score and Model for End-State Liver Disease Sodium for Predicting Posthepatectomy Liver Failure. Journal of Surgical Oncology, 126, 667-679. https://doi.org/10.1002/jso.26981
|
[10]
|
Garcea, G., Ong, S.L. and Maddern, G.J. (2009) Predicting Liver Failure Following Major Hepatectomy. Digestive and Liver Disease, 41, 798-806. https://doi.org/10.1016/j.dld.2009.01.015
|
[11]
|
Forner, A., Reig, M.E., de Lope, C.R., et al. (2010) Current Strategy for Staging and Treatment: The BCLC Update and Future Prospects. Seminars in Liver Disease, 30, 61-74. https://doi.org/10.1055/s-0030-1247133
|
[12]
|
Kudo, M., Chung, H. and Osaki, Y. (2003) Prognostic Staging Sys-tem for Hepatocellular Carcinoma (CLIP Score): Its Value and Limitations, and a Proposal for a New Staging System, the Japan Integrated Staging Score (JIS Score). Journal of Gastroenterology, 38, 207-215. https://doi.org/10.1007/s005350300038
|
[13]
|
Kitai, S., Kudo, M., Minami, Y., et al. (2008) Validation of a New Prognostic Staging System for Hepatocellular Carcinoma: A Comparison of the Biomarker-Combined Japan Integrated Staging Score, the Conventional Japan Integrated Staging Score and the BALAD Score. Oncology, 75, 83-90. https://doi.org/10.1159/000173428
|
[14]
|
Bruix, J., Cheng, A.L., Meinhardt, G., et al. (2017) Prognostic Factors and Predictors of Sorafenib Benefit in Patients with Hepatocellular Carcinoma: Analysis of Two Phase III Studies. Journal of Hepatology, 67, 999-1008.
https://doi.org/10.1016/j.jhep.2017.06.026
|
[15]
|
Cescon, M., Cucchetti, A., Grazi, G.L., et al. (2009) Indication of the Extent of Hepatectomy for Hepatocellular Carcinoma on Cirrhosis by a Simple Algorithm Based on Preoperative Variables. The Archives of Surgery, 144, 57-63.
https://doi.org/10.1001/archsurg.2008.522
|
[16]
|
Kamath, P.S., Wiesner, R.H., Malinchoc, M., et al. (2001) A Mod-el to Predict Survival in Patients with End-Stage Liver Disease. Hepatology, 33, 464-470. https://doi.org/10.1053/jhep.2001.22172
|
[17]
|
Ross Samuel, W., Seshadri, R., Walters, A.L., et al. (2016) Mortality in Hepatectomy: Model for End-Stage Liver Disease as a Predictor of Death Using the National Surgical Quality Im-provement Program Database. Surgery, 159, 777-792. https://doi.org/10.1016/j.surg.2015.08.021
|
[18]
|
Brown, C., Aksan, N. and Muir, A.J. (2022) MELD-Na Accurately Predicts 6-Month Mortality in Patients with Decompensated Cirrhosis: Potential Trigger for Hospice Referral. Journal of Clinical Gastroenterology, 56, 902-907.
https://doi.org/10.1097/MCG.0000000000001642
|
[19]
|
Natkha, V.P., Southerland, P., Almekdash, M.H., et al. (2023) Predicting Outcomes in Trauma Patients with Cirrhosis Using Model for End-Stage Liver Disease Score: A Ret-rospective Study. The American Surgeon, 89, 2383-2390.
https://doi.org/10.1177/00031348221093534
|
[20]
|
De Gasperi, A., Mazza, E. and Prosperi, M. (2016) Indocyanine Green Kinetics to Assess Liver Function: Ready for a Clinical Dynamic Assessment in Major Liver Surgery? World Journal of Hepatology, 8, 355-367.
https://doi.org/10.4254/wjh.v8.i7.355
|
[21]
|
Kokudo, N. and Makuuchi, M. (2009) Evidence-Based Clinical Practice Guidelines for Hepatocellular Carcinoma in Japan: The J-HCC Guidelines. Journal of Gastroenterology, 44, 119-121. https://doi.org/10.1007/s00535-008-2244-z
|
[22]
|
Greco, E., Nanji, S., Bromberg, I.L., et al. (2011) Predictors of Peri-Opertative Morbidity and Liver Dysfunction after Hepatic Resection in Patients with Chronic Liver Disease. HPB (Oxford), 13, 559-565.
https://doi.org/10.1111/j.1477-2574.2011.00329.x
|
[23]
|
Imamura, H., Seyama, Y., Kokudo, N., et al. (2003) One Thousand Fifty-Six Hepatectomies without Mortality in 8 Years. The Archives of Surgery, 138, 1198-1206. https://doi.org/10.1001/archsurg.138.11.1198
|
[24]
|
Seyama, Y. and Kokudo, N. (2009) Assessment of Liver Func-tion for Safe Hepatic Resection. Hepatology Research, 39, 107-116. https://doi.org/10.1111/j.1872-034X.2008.00441.x
|
[25]
|
Lee, C.F., Yu, M.C., Kuo, L.M., et al. (2007) Using In-docyanine Green Test to Avoid Post-Hepatectomy Liver Dysfunction. Chang Gung Medical Journal, 30, 333-338.
|
[26]
|
Kim, H.J., Kim, C.Y., Park, E.K., Hur, Y.H., Koh, Y.S., et al. (2015) Volumetric Analysis and Indocya-nine Green Retention Rate at 15 Min as Predictors of Post-Hepatectomy Liver Failure. HPB, 17, 159-167.
https://doi.org/10.1111/hpb.12295
|
[27]
|
Vos, J.J., Wietasch, J.K., Absalom, A.R., et al. (2014) Green Light for Liver Function Monitoring Using Indocyanine Green? An Overview of Current Clinical Applications. Anaesthesia, 69, 1364-1376.
https://doi.org/10.1111/anae.12755
|
[28]
|
董家鸿, 郑树森, 陈孝平, 等. 肝切除术前肝脏储备功能评估的专家共识(2011版) [J]. 中华消化外科杂志, 2011, 10(1): 20-25.
|
[29]
|
Martínez, S.M., Crespo, G., Navasa, M., et al. (2011) Noninvasive Assessment of Liver Fibrosis. Hepatology, 53, 325- 335. https://doi.org/10.1002/hep.24013
|
[30]
|
Wong, G.L., Chan, H.L., Wong, C.K., et al. (2014) Liver Stiffness-Based Optimization of Hepatocellular Carcinoma Risk Score in Patients with Chronic Hepatitis B. Journal of Hepatology, 60, 339-345.
https://doi.org/10.1016/j.jhep.2013.09.029
|
[31]
|
Lee, H.W., Yoo, E.J., Kim, B.K., et al. (2014) Prediction of De-velopment of Liver-Related Events by Transient Elastography in Hepatitis B Patients with Complete Virological Re-sponse on Antiviral Therapy. The American Journal of Gastroenterology, 109, 1241-1249. https://doi.org/10.1038/ajg.2014.157
|
[32]
|
Paefgen, V., Doleschel, D. and Kiessling, F. (2015) Evolution of Con-trast Agents for Ultrasound Imaging and Ultrasound-Mediated Drug Delivery. Frontiers in Pharmacology, 15, Article No. 197.
https://doi.org/10.3389/fphar.2015.00197
|
[33]
|
Chernyak, V., Fowler, K.J., Kamaya, A., et al. (2018) Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients. Radi-ology, 289, 816-830.
https://doi.org/10.1148/radiol.2018181494
|
[34]
|
Zheng, S.G., Xu, H.X. and Liu, L.N. (2014) Management of Hepatocellular Carcinoma: The Role of Contrast-Enhanced Ultrasound. World Journal of Radiology, 6, 7-14. https://doi.org/10.4329/wjr.v6.i1.7
|
[35]
|
Cho, K., Wang, X., Nie, S., et al. (2018) Therapeutic Nanoparticles for Drug Delivery in Cancer. Clinical Cancer Research, 14, 1310-1316. https://doi.org/10.1158/1078-0432.CCR-07-1441
|
[36]
|
Go, Y., Lee, H., Jeong, L., et al. (2018) Acid-Triggered Echogenic Nanoparticles for Contrast-Enhanced Ultrasound Imaging and Therapy of Acute Liver Failure. Biomaterials, 186, 22-30.
https://doi.org/10.1016/j.biomaterials.2018.09.034
|
[37]
|
Capussotti, L., Muratore, A., Amisano, M., et al. (2006) Liver Resection for Large-Size Hepatocellular Carcinomas in 47 Non-Cirrhotic Patients—No Mortality and Long-Term Survival. Hepatogastroenterology, 53, 768-772.
|
[38]
|
Tu, R., Xia, L.-P., Yu, A.-L., et al. (2007) Assessment of Hepatic Functional Reserve by Cirrhosis Grading and Liver Volume Measurement Using CT. World Journal of Gastroenterolo-gy, 13, 3956-3961.
https://doi.org/10.3748/wjg.v13.i29.3956
|
[39]
|
Bogner, A., Reissfelder, C., Striebel, F., et al. (2021) Intraoperative Increase of Portal Venous Pressure Is an Immediate Predictor of Posthepatectomy Liver Failure after Major Hepatectomy: A Prospective Study. Annals of Surgery, 274, e10-e17. https://doi.org/10.1097/SLA.0000000000003496
|
[40]
|
Ghibellini, G., Leslie, E.M., Pollack, G.M., et al. (2008) Use of tc-99m Mebrofenin as a Clinical Probe to Assess Altered Hepatobiliary Transport: Integration of in Vitro, Pharmaco-kinetic Modeling, and Simulation Studies. Pharmaceutical Research, 25, 1851-1860. https://doi.org/10.1007/s11095-008-9597-0
|
[41]
|
Liu, X., Jiang, H., Chen, J., et al. (2017) Gadoxetic Acid Diso-dium-Enhanced Magnetic Resonance Imaging Outperformed Multidetector Computed Tomography in Diagnosing Small Hepatocellular Carcinoma: A Meta-Analysis. Liver Transplantation, 23, 1505-1518. https://doi.org/10.1002/lt.24867
|
[42]
|
Rassam, F., Zhang, T., Cieslak, K.P., et al. (2019) Comparison between Dy-namic Gadoxetate-Enhanced MRI and 99mTc-Mebrofenin Hepatobiliary Scintigraphy with SPECT for Quantitative As-sessment of Liver Function. European Radiology, 29, 5063-5072. https://doi.org/10.1007/s00330-019-06029-7
|
[43]
|
Erdogan, D., Heijnen, B.H.M., Bennink, R.J., et al. (2004) Pre-operative Assessment of Liver Function: A Comparison of 99mTc-Mebrofenin Scintigraphy with Indocyanine Green Clearance Test. Liver International, 24, 117-123.
https://doi.org/10.1111/j.1478-3231.2004.00901.x
|
[44]
|
Chang, C.C., Huang, H.C., Liu, K., et al. (2016) Clinical Feasibility of GD-EOB-DTPA Enhanced MR Imaging for Assessing Liver Function: Validation with ICG Tests and Parenchymal Cell Volume. Clinical Imaging, 40, 797-800.
https://doi.org/10.1016/j.clinimag.2016.03.003
|
[45]
|
Araki, K., Harimoto, N., Yamanaka, T., et al. (2020) Efficiency of Regional Functional Liver Volume Assessment Using GD-EOB-DTPA-Enhanced Magnetic Resonance Imaging for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus. Surgery Today, 50, 1496-1506. https://doi.org/10.1007/s00595-020-02062-y
|
[46]
|
de Graaf, W., van Lienden, K.P., van Gulik, T.M., et al. (2010) (99m)Tc-mebrofenin Hepatobiliary Scintigraphy with SPECT for the Assessment of Hepatic Function and Liver Func-tional Volume before Partial Hepatectomy. Journal of Nuclear Medicine, 51, 229-236. https://doi.org/10.2967/jnumed.109.069724
|
[47]
|
Nanashima, A., Abo, T., Kudo, T., et al. (2013) Usefulness of Examining Hepatic Functional Volume Using Technetium-99m Galactosyl Serum Albumin Scintigraphy in Hepatocellu-lar Carcinoma. Nuclear Medicine Communications, 34, 478-488. https://doi.org/10.1097/MNM.0b013e32835f945f
|
[48]
|
Sugai, Y., Komatani, A., Hosoya, T., et al. (2000) Re-sponse to Percutaneous Transhepatic Portal Embolization: New Proposed Parameters by99mTc-GSA SPECT and Their Usefulness in Prognostic Estimation after Hepatectomy. Journal of Nuclear Medicine, 41, 421-425.
|
[49]
|
Kaibori, M., Ha-Kawa, S.K., Ishizaki, M., et al. (2008) HA/GSA-Rmaxratio as a Predictor of Postoperative Liver Failure. World Journal of Surgery, 32, 2410-2418. https://doi.org/10.1007/s00268-008-9725-3
|